Gut microbiome and its association with sociodemographic and clinical characteristics in Peruvian women with breast cancer: results of a multicenter study
This multicenter study of Peruvian women with breast cancer reveals that while the overall gut microbiome structure remains stable regardless of geographic origin, clinical stage, or molecular subtype, significant regional variations exist in the Firmicutes/Bacteroidota ratio.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Breast cancer is a relentless force, the most common cancer affecting women across the globe and a leading cause of cancer-related death. While scientists have long understood that genetics, hormones, and lifestyle play major roles in how this disease starts and spreads, a newer field of inquiry is turning its attention to the trillions of tiny organisms living inside us. This community, known as the gut microbiome, acts as a bustling ecosystem within our intestines, helping to digest food, train our immune system, and even influence how our bodies process hormones. Recent research suggests that the specific mix of bacteria in our gut might not just be a passenger in our health, but an active participant in the development of cancer. However, most of what we know about this connection comes from studies in wealthy nations, leaving a vast gap in our understanding of how these microscopic communities function in diverse populations with different diets, environments, and genetic backgrounds.
In Peru, where breast cancer rates are rising and the population carries a unique blend of genetic and cultural traits, a team of researchers set out to fill this gap. They wanted to see if the gut bacteria of women with breast cancer in Peru looked different depending on where they lived, how advanced their cancer was, or what specific type of tumor they had. To do this, they gathered a group of 77 women from three distinct regions of the country: the capital city of Lima in the center, the northern city of Trujillo, and the southern city of Arequipa. These women, all diagnosed with breast cancer but not currently taking antibiotics or probiotics, provided stool samples that were carefully analyzed in a laboratory. The scientists used a technique that reads the genetic code of the bacteria to identify exactly which species were present and in what numbers, creating a detailed map of the microbial landscape for each patient.
The results painted a picture of a shared biological foundation rather than a collection of radically different worlds. Across all three cities, the researchers found a common "core" group of bacteria that dominated the gut of these women. The most abundant genus, a type of bacteria called Faecalibacterium, made up nearly 15 percent of the community, followed by other groups like Segatella, Blautia, and Bacteroides. This consistency suggests that despite the vast distances and different local environments between Lima, Trujillo, and Arequipa, the gut microbiomes of these women with breast cancer share a fundamental structure. When the scientists looked at the overall diversity of these bacterial communities, they found no significant differences between the three cities. The variety of species in the gut was remarkably similar, regardless of whether a woman lived in the north, center, or south of the country.
The study also tested whether the specific characteristics of the cancer itself shaped the gut bacteria. The researchers examined if the stage of the disease, ranging from early to advanced, or the molecular subtype of the tumor, such as hormone-positive or triple-negative, made a difference. They found no evidence to support this idea. The gut microbiome did not change in a predictable way based on how large the tumor was or what kind of cancer it was. This suggests that for these women, the internal environment of the tumor does not seem to be the primary driver of their gut bacterial composition. Instead, factors like the patient's age and body mass index appeared to have a similar, if not greater, influence on the microbiome than the cancer itself.
However, the study did uncover a subtle but significant geographic signal, though it was not a difference in the types of bacteria present, but rather in the balance between two major groups. The researchers measured the ratio of two large families of bacteria, the Firmicutes and the Bacteroidota. They found that this balance shifted depending on the region. Women in Trujillo had the highest ratio of these two groups, while women in Arequipa had the lowest, with Lima falling somewhere in between. This difference was statistically significant, indicating that while the overall community structure remained stable, the relative abundance of these major groups varied in a gradient across the country. It is a bit like a choir singing the same song in three different cities; the singers are the same, but the volume of certain sections varies slightly from one location to another.
Ultimately, this research provides a crucial baseline for understanding breast cancer in Latin America, a region that has been largely overlooked in microbiome studies. The findings suggest that the gut microbiota in Peruvian women with breast cancer is a relatively stable community that is not drastically altered by the specific geography of the patient, the stage of their cancer, or the molecular type of their tumor. While there are modest regional variations in the balance of bacterial groups, the overall picture is one of consistency. The study highlights that environmental and host factors, such as diet and body weight, may play a more dominant role in shaping the gut microbiome than the intrinsic characteristics of the tumor. By establishing this foundation, the researchers have opened the door for future studies to explore how these microbial communities interact with treatments and disease progression in this diverse population, moving closer to a more complete understanding of breast cancer in Peru.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.